Pfizer (NYSE:PFE) recently announced positive topline results from its Phase 3 BASIS study for HYMPAVZI™ and declared a third-quarter 2025 dividend of $0.43 per share. Alongside these developments, ...

The Schwab U.S. Dividend Equity ETF yields around 4% today, which means that it would take an investment of approximately $50 ...

The dividend record date is when a company finalises eligible shareholders for dividend, e.g., if a company sets June 27, ...

Pfizer (PFE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

For income-focused investors, these two Invesco ETFs provide exceptionally high yields with monthly dividends.

Pfizer has earned a consensus rating of “Moderate Buy” from fifteen analysts, with only one calling it a “sell.” The average ...